CTSS and colitis: In the Canadian cohort, where mucosal cathepsin S was marginally increased after DSS treatment compared to naïve colons, with no demonstrable increase of cathepsin S secretion, genetic deletion of cathepsin S resulted in marginal improvement of some, but not all, symptoms of colitis.